Background: Proton (H ϩ ) secretion and the HVCN1 H ϩ channel are part of the innate host defense mechanism of the airways. The objective of this study was to determine H ϩ secretion in asthmatic and nonasthmatic patients with chronic rhinosinusitis (CRS) in freshly excised human sinonasal tissue.
I nnate host defense mechanisms of the airways continuously protect against inhaled pathogens. 1 The mucosa of the airway surface epithelium is covered with a thin layer of fluid called airway surface liquid (ASL). 2 The composition of the ASL affects its physiological functions, the most important of which are removal of inhaled infectious particles and antimicrobial activity. 3 It is believed that ASL is normally acidic relative to blood pH and studies of ASL pH have measured values in vivo of ϳ6.6 in the airways of normal humans using a bronchoscopically directed pH electrode and ϳ7.1 in the surgically exposed trachea of normal mice using a pH-sensitive fluorescent dye. 4, 5 These studies also suggest that the airway epithelium expresses cellular processes that regulate ASL pH. ASL pH is altered by disease and airway inflammation, and acidification of the ASL is promoted by airway inflammation. 4, 6 Previously, it was shown that the airway epithelium secretes acid by way of apical proton channels. 2 Excessive acidification of the luminal pH is predicted to have effects on the innate immune responses and likely suppresses microbe clearance from the respiratory tract by hindering the mucociliary escalator and by reducing phagocytic activity. 7 Rhinosinusitis is one of the most common comorbidities in patients with asthma and the coexistence of these conditions has been recognized. In patients with asthma, inflammation in the nose and sinuses share features of disease of the distal airways. Although common
METHODS

Study Subjects
This study was approved by the institutional review boards at Stanford University and Children's Hospital Oakland Research Institute. Normal sinonasal mucosa was obtained intraoperatively from patients undergoing endoscopic surgery for pituitary tumor, benign sinonasal tumor, or lacrimal obstruction. Diseased sinonasal mucosa was also taken from medically refractory CRS patients with or without asthma during endoscopic sinus surgery. All patients fulfilled diagnostic criteria for CRS developed by the Task Force for Defining Adult Chronic Rhinosinusitis and endorsed by the American Academy of Otolaryngology-Head and Neck Surgery, and had failed medical management. 11 Tissues from asthmatic patients were from patients who had been diagnosed in accordance with the American Thoracic Society at least 12 months before surgery. 12 Specimens from nasal septum and turbinates were categorized as nasal tissue and those from uncinate process and ethmoid sinus were categorized as sinus tissue. In total, six groups of sinonasal specimens were collected: (1) normal nasal epithelia, (2) normal sinus epithelia, (3) nasal epithelia from CRS without asthma, (4) sinus epithelia from CRS without asthma, (5) nasal epithelia from CRS with asthma, and (6) sinus epithelia from CRS with asthma. The following clinical parameters were assessed: presence of nasal polyps, allergy status, presence of eosinophils, computed tomography (CT) scores, and Sino-Nasal Outcomes Test-20 (SNOT-20). All tissue specimens that became available during the time of study were used resulting in study groups of different sizes.
Specimen Processing and pH Stat Measurements
After surgical removal, tissue specimens were stored immediately in ice-cold LHC-9 media (Invitrogen, Carlsbad, CA) and transferred to the laboratory for investigation. Proton secretion was measured using the pH stat titration method in an Ussing chamber (Physiologic Instruments, Inc., San Diego, CA). 13 Figure 1 shows a schematic of the measuring setup. A thin layer of epithelial tissue was dissected from the surgical specimen and mounted on sliders with apertures of 0.040-0.71 cm 2 and inserted between Ussing-type hemichambers. Tissues were bathed serosally with HEPES-buffered solution and mucosally with buffer-free solution (5 mL each). The bathing solutions were circulated by a gas-lift system at 37°C. The buffer-free solution on the mucosal (luminal) side contained 140 mM of NaCl, 2 mM of KCl, 15 glucose, 2 mM of CaCl 2 , and 1 mM of MgCl 2 and was continuously gassed with nitrogen to prevent air CO 2 from entering the solution. The HEPES-buffered solution on the serosal side contained 140 mM of NaCl, 2 mM of KCl, 5 mM of glucose, 10 mM of HEPES, 2 mM of CaCl 2 , and 1 mM of MgCl 2 and was gassed with oxygen. After the tissues were mounted in the chamber, the pH of the mucosal solution is determined by the H ϩ secretion of the tissue. The solution pH was allowed to equilibrate for ϳ15 minutes and the resulting pH was recorded as the equilibrium pH. The equilibrium pH remained stable within Ϯ0.02 pH units for up to 30 minutes. To measure the rate of proton secretion, the mucosal pH was continuously titrated to a target pH of 8.0 by a pH stat titration apparatus (TitraLab 856; Radiometer Analytical, Villeurbanne, France) using 1 mM of NaOH as a titrant. An alkaline mucosal pH was used to increase the driving force for H ϩ and amplify the measured signal. From the amount of base added at constant pH, the H ϩ secretion of the tissues was determined and is given in nanomoles per minute per centimeter squared. At the end of the experiment, 10 M of ZnCl 2 (a blocker of the H ϩ channel HVCN1 [hydrogen voltage-gated channel 1]) was added to the mucosal side to determine the role of apical H ϩ channels. 3
Statistical Analysis
Statistical analyses were performed using SPSS software (Version 15.0, SPSS Inc., Chicago, IL) and p Ͻ 0.05 was considered significant. Two-way and one-way ANOVA, Mann-Whitney rank sum test, or Kruskal-Wallis one-way analysis of variance of ranks followed by the Dunn multiple comparison tests were used as appropriate. Data are given as individual measurements or as mean Ϯ SE.
RESULTS
Patient Factors
Comorbidity characteristics (presence of polyps, allergy status, and presence of eosinophils) are described in Table 1 ; 27.8 and 44.4% of the patients with CRS without and with asthma had nasal polyposis. None of the patients had other comorbidities such as aspirin intolerance, mucociliary dysfunction, or immune deficiency. CRS with asthma had worsened CT scores than patients without asthma (p ϭ 0.014; Table 2 ). Asthma did not have an effect on the SNOT-20, even though CRS with asthma had higher scores compared with patients without asthma ( Table 2 ).
Equilibrium pH
Individual and average values of the equilibrium pH from sinus and nasal epithelia are shown in Fig. 2 . Average equilibrium pH values were for nasal tissues: 7.35 Ϯ 0.21 (normal, n ϭ 5), 7.33 Ϯ 0.15 (CRS without asthma, n ϭ 5), and significantly reduced to 6.95 Ϯ 0.34 in CRS with asthma (n ϭ 5). Average equilibrium pH values for nasal tissues were 7.28 Ϯ 0.21 (normal, n ϭ 2), 7.44 Ϯ 0.10 (CRS without asthma, n ϭ 6), and 7.33 Ϯ 0.24 (CRS with asthma, n ϭ 4). The tissue types (nasal versus sinus) or disease status (normal versus CRS without asthma versus CRS with asthma) did not show significant effects on measurements (two-way ANOVA, p ϭ 0.181). Within the nasal tissue group, the equilibrium pH of nasal epithelia from CRS with asthma was significantly lower compared with nasal epithelia from normal and CRS without asthma (p ϭ 0.037; Fig. 2 ). For comparison, equilibrium pH values measured in sinus tissues were not different among the three different disease groups (normal, CRS without asthma, and CRS with asthma).
Proton Secretion across Freshly Excised Human Nasal Epithelia
The basis for the differences of the equilibrium pH was further investigated in nasal tissues by determining the rates of H ϩ secretion. This was done with a constant pH of 8.0 on the mucosal side to apply a consistent driving force. Under these conditions, nasal tissues secreted acid at average rates of 73.3 Ϯ 39.3 nmol⅐min Ϫ1 ⅐cm Ϫ2 (normal, n ϭ 8), 51.4 Ϯ 27.7 nmol⅐min Ϫ1 ⅐cm Ϫ2 (CRS without asthma, n ϭ 7), and at a significantly increased rate of 135.1 Ϯ 46.2 nmol⅐min Ϫ1 ⅐cm Ϫ2 in CRS with asthma (p ϭ 0.005; n ϭ 5; Fig. 3 ). These data indicate that the reduced mucosal pH in nasal tissues from CRS with asthma is the result of an increased rate of acid secretion. Epithelial tissue, dissected from the surgical specimen, was mounted between the two chamber halves and bathed serosally with HEPES-buffered solution and mucosally with buffer-free solution (5 mL each). Solutions were gassed with oxygen (serosal) and nitrogen (mucosal), respectively. The pH of the mucosal solution was continuously titrated to a target pH of 8.0 using a pH stat titration apparatus. 
Proton Channel Blocker Experiment
Next, we tested the role of apical H ϩ channels in acid secretion in excised nasal tissues. Exposure of the mucosal surface to ZnCl 2 (10 M, a HVCN1 H ϩ channel blocker) significantly reduced proton secretion across all nasal tissues (Fig. 4 ). Mucosal addition of ZnCl 2 blocked acid secretion by, on average, 71% (normal), 53% (CRS without asthma), and 51% (CRS with asthma), indicating a role of HVCN1 H ϩ channels in acid secretion by these tissues. The ZnCl 2 effect was significantly larger in normal nasal tissues (p ϭ 0.043) compared with the CRS tissues, suggesting that CRS reduces the relative contribution of the HVCN1 H ϩ channel to acid secretion.
DISCUSSION
To our knowledge, this is the first study that measured acid secretion of freshly excised sinonasal human tissues. We report both the equilibrium pH and the rates of acid secretion in normal controls and CRS patients. As others have previously noted, patients with asthma had worse CT scores than CRS patients without asthma. 14 Our main finding is that nasal (but not sinus) epithelia from CRS patients with asthma had both a significantly reduced mucosal equilibrium pH and an increased H ϩ secretion compared with nasal tissues from normal or CRS patients. In our study, the average nasal equilibrium pH in normal patients (7.35 ) and in patients with CRS with asthma (6.95) is similar to recent findings of induced sputum pH measured in normal patients (7.54) and asthmatic patients (7.06). 15 In contrast, most other pH studies in asthmatic patients have been done on exhaled breath condensate, where the measured pH tends to be more alkaline in normals (pH ϭ 8) and more acidic in asthmatic patients (pH ϭ 5.2), which is likely caused by the sample processing and CO 2 degassing during these measurements. 9, 16 Within the group of CRS patients with asthma, patients with nasal polyps had lower mucosal equilibrium pH (6.5 and 6.6) compared with those from patients without nasal polyps (pH, ϳ7.2), suggesting that acid release in these subjects was further increased.
Airway epithelial cells express multiple mechanisms to secrete protons across the apical membrane into the ASL. For example, an ATP-driven apical mechanism has been identified that secretes H ϩ against a pH gradient into an acidic ASL. 17, 18 In addition, passive gradient-driven H ϩ release governed by apical H ϩ channels has been described in cultured human tracheal epithelia. 2 H ϩ channels may be a part of the airway NADPH oxidase defense system where H ϩ channels function to release intracellular H ϩ that is produced by NADPH oxidases during mucosal defense as proposed recently. 19, 20 Harper et al. showed that the airway NADPH oxidase Duox1 and Duox2 were up-regulated by the inflammatory cytokines IL-4, IL-13, and interferon ␥. 21 In addition, airway acidification in asthmatic patients has been observed by measuring the pH of exhaled breath condensate, which was Ͼ2 pH units more acidic than measurements in normal controls. 9 Similarly, our data from freshly excised nasal tissue showed lower values of equilibrium pH and higher acid secretion in CRS patients with asthma. This observation suggests that it may be important to consider airway pH when interpreting the pathophysiology of asthmatic and allergic diseases in patients with CRS. 9 Measurement of nasal pH may prove clinically useful as an outcome measure in CRS and may correlate with some of the differences in clinical severity notable among asthmatic patients with CRS. Furthermore, we speculate that therapies directed at normalizing nasal airway pH may help to prevent the cascade of events that leads to sinonasal diseases or exacerbation of airway inflammation. The quantitative contribution of individual H ϩ secretory mechanisms may be different under experimental circumstances. Schwarzer et al. noted that the H ϩ channel contributed to 49% of total H ϩ secretion as determined from blocker experiments in primary cultures of human tracheal epithelial cells. 20 In our experiments using freshly excised human nasal epithelial tissues, 70% of total H ϩ secretion was caused by H ϩ channels in normal nasal epithelia, 53% in CRS, and 51% in CRS with asthma. The rate of proton secretion in Zn 2ϩexposed nasal epithelia from CRS with asthma was equal to the rate in normal nasal epithelia without the blocker. Based on these data, Zn 2ϩ -sensitive H ϩ channels contribute more to the total H ϩ secretion in normal nasal epithelia, compared with contribution in nasal epithelia from CRS with or without asthma, suggesting that CRS and asthma up-regulate the contribution of H ϩ secretory mechanisms other than H ϩ channels.
CONCLUSIONS
Surgical specimens from freshly excised nasal mucosa secreted H ϩ across the mucosal membrane into an alkaline ASL by a mechanism that was in part mediated by the Zn 2ϩ -sensitive H ϩ channel (HVCN1). Our data suggest that inflammatory processes in CRS with asthma may lead to enhanced H ϩ secretion by the nasal airway epithelium and acidify the ASL. It is possible that ASL acidification is predicted to negatively impact the innate immune system and is a significant step during airway inflammation and infection in CRS with asthma.
